| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |